Got a booster?
The United States plans to move up the COVID-19 booster shots to six months instead of eight.
The U.S. Food and Drug Administration could soon approve a third coronavirus shot and remove the eight-month gap, according to The Wall Street Journal.
Approval of boosters for three COVID-19 shots being administered in the United States — those manufactured by Pfizer Inc and partner BioNTech SE, Moderna Inc and Johnson & Johnson — is expected in mid-September, the report said, citing a person familiar with the plans.
Pfizer and BioNTech have already started the application process for the approval of its booster shot in people 16 and older, saying it spurs a more than three-fold increase in antibodies against the coronavirus.
Earlier this week, U.S. regulators granted full approval to Pfizer’s two-dose vaccine. Moderna said on Wednesday it has completed the real-time review needed for a full approval for its jab in people 18 and above.
How many more boosters will Americans need?
Leave a Comment